A novel series of chromene-based TNF-alpha inhibitors is described. These chromene derivatives inhibit bacterial lipopolysaccharide (LPS) stimulated production of TNF-alpha from human peripheral blood mononuclear cells (PBMC). Additionally, these compounds inhibit NF-kB mediated transcription activation. (C) 2003 Elsevier Ltd. All rights reserved.
A novel series of chromene-based TNF-alpha inhibitors is described. These chromene derivatives inhibit bacterial lipopolysaccharide (LPS) stimulated production of TNF-alpha from human peripheral blood mononuclear cells (PBMC). Additionally, these compounds inhibit NF-kB mediated transcription activation. (C) 2003 Elsevier Ltd. All rights reserved.
[EN] BENZOPYRANES USEFUL AS TNF ALPHA INHIBITORS<br/>[FR] BENZOPYRANES UTILES COMME INHIBITEURS DE TNF-ALPHA
申请人:CHUGAI PHARMACEUTICAL CO LTD
公开号:WO2001072735A2
公开(公告)日:2001-10-04
This invention relates to novel compounds of formula (I) capable of inhibiting TNF alpha and having antiinflammatory properties useful in a pharmaceutical composition, such as for a drug containing this as an active ingredient; and a therapeutic method with the use of these novel compounds.
A novel series of chromene-based TNF-alpha inhibitors is described. These chromene derivatives inhibit bacterial lipopolysaccharide (LPS) stimulated production of TNF-alpha from human peripheral blood mononuclear cells (PBMC). Additionally, these compounds inhibit NF-kB mediated transcription activation. (C) 2003 Elsevier Ltd. All rights reserved.